BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16464554)

  • 1. MR contrast agents in lymph node imaging.
    Misselwitz B
    Eur J Radiol; 2006 Jun; 58(3):375-82. PubMed ID: 16464554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography.
    Misselwitz B; Platzek J; Radüchel B; Oellinger JJ; Weinmann HJ
    MAGMA; 1999 Aug; 8(3):190-5. PubMed ID: 10504047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contrast media for magnetic resonance tomographic lymph node diagnosis (MR lymphography)].
    Taupitz M; Wagner S; Hamm B
    Radiologe; 1996 Feb; 36(2):134-40. PubMed ID: 8867430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
    Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
    Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial T1-weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs.
    Staatz G; Nolte-Ernsting CC; Adam GB; Grosskortenhaus S; Misselwitz B; Bücker A; Günther RW
    Radiology; 2001 Jul; 220(1):129-34. PubMed ID: 11425984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early MR lymphography with gadofluorine M in rabbits.
    Misselwitz B; Platzek J; Weinmann HJ
    Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
    Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
    Radiographics; 2009; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
    Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
    Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.
    Anzai Y; Prince MR
    J Magn Reson Imaging; 1997; 7(1):75-81. PubMed ID: 9039596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental lymph node metastases: enhanced detection with MR lymphography.
    Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
    Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
    Bellin MF; Lebleu L; Meric JB
    Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA; Saokar A; Harisinghani MG
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.
    Herborn CU; Vogt FM; Lauenstein TC; Goyen M; Dirsch O; Corot C; Debatin JF; Ruehm SG
    J Magn Reson Imaging; 2003 Sep; 18(3):328-35. PubMed ID: 12938128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
    Mohr U; Weissleder R
    Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
    Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
    J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
    Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
    Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
    Spuentrup E; Ruhl K; Weigl S; Misselwitz B; Wardeh D; Buhl A; Botnar RM; Katoh M; Wiethoff AJ; Günther RW
    Rofo; 2010 Aug; 182(8):698-705. PubMed ID: 20419610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.